Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

about

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

Item

http://www.wikidata.org/entity/Q55040628

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@en

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@nl

type

Item

label

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@en

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@nl

prefLabel

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@en

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure.

@nl

P1476

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure

@en

P2093

Merlin C Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

30 Years of the Mineralocorticoid Receptor: Mineralocorticoid receptor antagonists: 60 years of research and development.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Risk prediction models for hospital readmission: a systematic review.

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.

P304

1179546818779588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1179546818779588

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Merlin Thomas

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29899670

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5992798

http://www.w3.org/2001/XMLSchema#string